Literature DB >> 1310837

Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes.

D M Koelle1, J Benedetti, A Langenberg, L Corey.   

Abstract

OBJECTIVE: To determine frequency, anatomic site, and host factors associated with asymptomatic shedding of herpes simplex virus after initial episodes of genital herpes.
DESIGN: Cohort study with follow-up for a median of 63 weeks.
SETTING: Referral clinic. PATIENTS: Women (306) with first episode of herpes; 43 had primary herpes simplex virus type 1, and 227 and 36 had primary and nonprimary herpes simplex virus type 2, respectively. MEASUREMENTS: Cultures were obtained for herpes simplex virus every 4 to 6 weeks at times in which genital lesions and symptoms were not present. MAIN
RESULTS: Asymptomatic shedding was detected among 11.9%, 18.3%, and 22.9% of women with primary herpes simplex virus type 1, primary HSV type 2, and nonprimary HSV type 2, respectively. Among patients with type 2 infection, previous type 1 antibody was associated with a lower rate of asymptomatic vulvar shedding. Asymptomatic cervical shedding was 3 times more frequent during the first three months after resolution of primary type 2 disease than during later time periods. In contrast, the rate of symptomatic recurrent herpes did not change over time.
CONCLUSIONS: Asymptomatic genital herpes simplex type 2 is more common than type 1. Asymptomatic genital shedding occurs more often during the first 3 months after acquisition of primary type 2 disease than during later periods. Patients with HSV type 2 should be advised of this high early rate of asymptomatic shedding and of potential transmission to sexual partners.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310837      PMCID: PMC4084907          DOI: 10.7326/0003-4819-116-6-433

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  27 in total

1.  Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes.

Authors:  B V Brock; S Selke; J Benedetti; J M Douglas; L Corey
Journal:  JAMA       Date:  1990-01-19       Impact factor: 56.272

2.  Acquisition of genital herpes from an asymptomatic sexual partner.

Authors:  J F Rooney; J M Felser; J M Ostrove; S E Straus
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

3.  Intravenous acyclovir for the treatment of primary genital herpes.

Authors:  L Corey; K H Fife; J K Benedetti; C A Winter; A Fahnlander; J D Connor; M A Hintz; K K Holmes
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

4.  Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type.

Authors:  W E Lafferty; R W Coombs; J Benedetti; C Critchlow; L Corey
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

5.  Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts.

Authors:  G J Mertz; O Schmidt; J L Jourden; M E Guinan; M L Remington; A Fahnlander; C Winter; K K Holmes; L Corey
Journal:  Sex Transm Dis       Date:  1985 Jan-Mar       Impact factor: 2.830

6.  Screening to detect asymptomatic shedding of herpes simplex virus (HSV) in women with recurrent genital HSV infection.

Authors:  S E Barton; L K Wright; C M Link; P E Munday
Journal:  Genitourin Med       Date:  1986-06

Review 7.  Treatment of genital herpes.

Authors:  K M Stone; W L Whittington
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

8.  Persistence of virus shedding in asymptomatic women after recovery from herpes genitalis.

Authors:  E Adam; R H Kaufman; R R Mirkovic; J L Melnick
Journal:  Obstet Gynecol       Date:  1979-08       Impact factor: 7.661

9.  Acyclovir in first attacks of genital herpes and prevention of recurrences.

Authors:  A Mindel; I V Weller; A Faherty; S Sutherland; A P Fiddian; M W Adler
Journal:  Genitourin Med       Date:  1986-02

Review 10.  Genital herpes simplex virus infections: clinical manifestations, course, and complications.

Authors:  L Corey; H G Adams; Z A Brown; K K Holmes
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

View more
  45 in total

1.  Genital herpes, "the new paradigm".

Authors:  S Taylor; S Drake; D Pillay
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

2.  Prodromal symptoms in genital herpes simplex infection.

Authors:  J L Brookes; S Haywood; J Green
Journal:  Genitourin Med       Date:  1992-10

3.  Recent developments in genital herpes.

Authors:  S Shafran; J Conly
Journal:  Can J Infect Dis       Date:  1992-07

Review 4.  Oral sex and the transmission of viral STIs.

Authors:  S Edwards; C Carne
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

Review 5.  Neurological disease produced by varicella zoster virus reactivation without rash.

Authors:  Don Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 6.  Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision.

Authors:  A Scoular
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

7.  Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa.

Authors:  Sunitha Tata; Christine Johnston; Meei-Li Huang; Stacy Selke; Amalia Magaret; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

8.  Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia.

Authors:  Kevin R Forward; Spencer Hs Lee
Journal:  Can J Infect Dis       Date:  2003-03

Review 9.  Use of the designation "shedder" in mucosal detection of herpes simplex virus DNA involving repeated sampling.

Authors:  A S Magaret; C Johnston; A Wald
Journal:  Sex Transm Infect       Date:  2009-02-11       Impact factor: 3.519

10.  Suppressive valacyclovir therapy to reduce genital herpes transmission: good public health policy?

Authors:  Paul E Bonnar
Journal:  Mcgill J Med       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.